RecruitingNot ApplicableNCT03594344

Additional Hyperbaric Oxygen After Lower Extremity Amputation

Additional Hyperbaric Oxygen After Lower Extremity Amputation - A Randomized Controlled Trial

Sponsor

Oslo University Hospital

Enrollment

120 participants

Start Date

Jul 4, 2018

Study Type

INTERVENTIONAL

Conditions

Osteomyelitis Diabetes Mellitus Amputation Diabetic Foot Diabetic Neuropathies Claudication, Intermittent Lower Extremity Ulcer Diabetic Angiopathy Critical Limb Ischemia

Summary

This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.

Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Hyperbaric oxygen therapy for people with amputation, claudication, intermittent, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.